✨ Medicines Distribution Consent




NEW ZEALAND GAZETTE, No. 182

27 NOVEMBER 2008

Schedule

Product: Codral Cold & Flu
Active Ingredients:

  • Codeine phosphate, hemihydrate 9.5mg equivalent to 7.03mg codeine
  • Paracetamol 500mg
  • Phenylephrine hydrochloride 5mg equivalent to 4.1mg phenylephrine
    Dosage Form: Tablet
    New Zealand Sponsor: Johnson & Johnson Pacific (New Zealand) Limited
    Manufacturer: Probiotec Pharma Pty Limited, Laverton North, Victoria, Australia

Product: Docetaxel Winthrop
Active Ingredient: Docetaxel trihydrate 40mg/mL
Dosage Form: Infusion Concentrate
Diluent
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers:

  • Aventis Pharma, Dagenham, Essex, United Kingdom
  • Pierre Fabre Medicament Production, Etablissement Aquitaine Pharm International, Idron, France

Product: Panadol Cold & Flu Max + Decongestant
Active Ingredients:

  • Paracetamol 500mg
  • Phenylephrine hydrochloride 5mg equivalent to 4.1mg phenylephrine
    Dosage Form: Tablet
    New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
    Manufacturer: GlaxoSmithKline Australia Pty Limited, Consumer Healthcare, Ermington, New South Wales, Australia

Dated this 21st day of November 2008.

MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).


Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Arabloc
Active Ingredient: Leflunomide 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Aventis Intercontinental, Compeigne, France

Product: Arabloc
Active Ingredient: Leflunomide 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Aventis Intercontinental, Compeigne, France

Product: Arabloc
Active Ingredient: Leflunomide 20mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Aventis Intercontinental, Compeigne, France

Product: Arava
Active Ingredient: Leflunomide 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Aventis Intercontinental, Compeigne, France

Product: Arava
Active Ingredient: Leflunomide 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Aventis Intercontinental, Compeigne, France



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2008, No 182





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
21 November 2008
Medicines, Distribution Consent, Codral Cold & Flu, Docetaxel Winthrop, Panadol Cold & Flu Max + Decongestant, Johnson & Johnson Pacific, sanofi-aventis, GlaxoSmithKline
  • MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate

πŸ₯ Consent to Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
Medicines, Distribution Consent, Arabloc, Arava, Leflunomide, sanofi-aventis, Aventis Intercontinental